Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesWomens ImagingWomen's Imaging MinnieCast, Episode 12: Educating the public on breast densityCo-founders of DenseBreast-info.org discuss their work in educating the public on breast density and cancer risk.Molecular ImagingPET/MRI can reduce the need for biopsies in prostate cancerDigital X-RaySocioeconomic conditions amplify pollution-related bone lossPractice ManagementMedicare Advantage cost-sharing varies for advanced imaging servicesWomens ImagingSNAP participation boosts cancer screening among food-insecure adults
